Long Zhun SARS-CoV-2 Rapid Test

TABP’s SARS-CoV-2 Antigen Rapid Test was technology transferred and developed from the biospecific Antibody provided from National Health Research Institute (NHRI) & Institute of Preventive Medicine (IPM), National Defense Medical Center (NDMC). 

Nucleic Acid, Antigen and Antibody are the 3 major targets been used for detecting SARS-CoV-2 infection internationally. Since the Antigen and Antibody rapid tests are handy that they do not need to rely on specific equipment nor operators with specialized medical background, as well as the time of operating the test could also be shortened from 4 hours to only 20 minutes compared to Nucleic Acid (qPCR) detecting method, the rapid tests are more effective and convenient when it comes to providing the frontline anti-infection work.

Antigen detection is designed for distinguishing the potential patients that are currently under infection, while the Antibody detection are provided for finding the potential infectors who have already been infected and may still be contagious. By combining all the 3 methods it could increase the effectiveness and accuracy of early stage screening to find out the potential infectors for evaluating the follow up anti-infection procedures or quarantine to avoid a further spread out.